Report: More Employers Are Looking To Deploy Value-Based Care
More than a third of employers are integrating accountable care into their health benefits, according to a new report from the Milken Institute. However, there are several barriers.
Why CMS is prioritizing value-based care and how healthcare companies can support this initiative
The road to value-based care is evolving as technology advances. An important tool for this journey is artificial intelligence and machine learning.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
What Morgan Health is doing in CA and OH to reinvent employer-sponsored health costs
On a panel discussion about employer-sponsored health benefits, the CEO of Morgan Health outlined some priorities and new efforts to reign in healthcare costs for employees while also providing them convenience and choice.
CMS’s Primary Cares initiative means providers and tech must collaborate
Eliminating the dependence on billable codes supports innovation in care delivery, but to better mitigate the financial risk, providers and technology suppliers must work better together to target, streamline, and monitor communications.
Where’s the value in accountable care?
Accountable care is supposed to be about paying for value. But six years after passage of the Affordable Care Act heralded the shift away from fee-for-service, Dr. Greg Carroll, corporate clinical leader of GOHealth Urgent Care, has an important question: "Where's the value?"
Let’s hope your Thanksgiving isn’t like this
You really have to feel for those whose points of contention at the Thanksgiving dinner table include health IT.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Mostashari’s Aledade hires ex-ONC interoperability guru Galvez
Erica Galvez, who led development of the federal government's Shared Nationwide Interoperability Roadmap, has rejoined a former boss in the private sector.
Mostashari’s Aledade to form new ACOs in 7 states
Aledade, a Bethesda, Md.-based startup that supports physician-led Accountable Care Organizations, has formally applied to establish new ACOs in seven states beginning in 2016.
5 key questions when caring for a relative with a health challenge
There is a significant effort underway in healthcare to ensure that patient and family goals guide the therapies and care that patients choose to receive.